Antidiabetic Drug
Global Antidiabetic Drug Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025
Report ID: BMRC 2414 | Number of pages: 192 | Publish Date: Jan 2020 | Category: Lifesciences and HealthcareThis study presents the Anti-diabetic drug production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. History breakdown data from 2014 to 2019, and forecast to 2025.
In 2019, the market size of Antidiabetic Drug is 49600 million US$ and it will reach 96700 million US$ in 2025, growing at a CAGR of 10.0% from 2019. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antidiabetic Drug.
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and ? cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
In global market, the following companies are covered:
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
This report studies the global market size of Antidiabetic Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antidiabetic Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
Market Segment by Product Type
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt?2
Thiazolodinediones
Market Segment by Application
Type I Diabetes
Type II Diabetes
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Table of Content Chapter 1 Global Antidiabetic Drug Market: Summary and Quantitative Analysis 1.1 Report Description 1.2 Global Antidiabetic Drug Market Revenue Overview 1.3 Global Antidiabetic Drug Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025 Chapter 2 Global Antidiabetic Drug Market: Overview and Qualitative Analysis 2.1 Executive Summary 2.2 Market Drivers 2.3 Market Restraints 2.4 Market Opportunities 2.5 Market Trends 2.6 Global Antidiabetic Drug Market: SWOT Analysis 2.7 Global Antidiabetic Drug Market: PEST Analysis 2.7 Global Antidiabetic Drug Market: Porter’s Five Forces Analysis 2.8 Global Antidiabetic Drug Market: Attractiveness Analysis 2.8.1 Global Antidiabetic Drug Market: Attractiveness Analysis by Type 2.8.2 Global Antidiabetic Drug Market: Attractiveness Analysis by Grade 2.8.3 Global Antidiabetic Drug Market: Attractiveness Analysis by Regional Chapter 3 Competitive Analysis 3.1 Global Antidiabetic Drug Market 3.1.1 Global Antidiabetic Drug market Revenue (USD Billion), By Players 2018 3.1.2 Global Antidiabetic Drug Market Revenue Share (%), By Players 2018 Chapter 5 Global Antidiabetic Drug Market: By Product Type 5.1 Global Antidiabetic Drug Market Share (%), By Product Type, 2018 5.2 Global Antidiabetic Drug Market Revenue (USD Billion), By Product Type, 2015 – 2025 5.3 Global Antidiabetic Drug Market Revenue (USD Billion), By Retro,2015-2025 5.4 Global Antidiabetic Drug Market Revenue (USD Billion), By Standing/Self-Balancing, 2015-2025 5.4 Global Antidiabetic Drug Market Revenue (USD Billion), By Folding, 2015-2025 5.5 Global Antidiabetic Drug Market Revenue Share (%), By Product Type, 2015 – 2025 5.6 Global Antidiabetic Drug Market Revenue Market Share (%), By Product Type, 2015-2025 Chapter 6 Global Antidiabetic Drug Market: By Product Type 6.1 Global Antidiabetic Drug Market Share (%), By Product Type, 2018 6.2 Global Antidiabetic Drug Market Revenue (USD Billion), By Type, 2015 – 2025 Chapter 7 North America Antidiabetic Drug Market Analysis 7.1 North America Market Snapshot 7.1.1 North America Antidiabetic Drug Market Revenue and Growth Rate (%), 2015-2025. 7.1.2 North America Antidiabetic Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 7.1.3 North America Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 7.1.5 North America Antidiabetic Drug Revenue (USD Billion) Overview, By Product Type, 2015-2025 7.1.6 North America Antidiabetic Drug Revenue (USD Billion) Overview, By Product Type , 2015-2025 Chapter 8 Europe Antidiabetic Drug Market Analysis 8.1 Europe Market Snapshot 8.1.1 Europe Antidiabetic Drug Market Revenue and Growth Rate (%), 2015-2025. 8.1.2 Europe Antidiabetic Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 8.1.3 Europe Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 8.1.5 Europe Antidiabetic Drug Revenue (USD Billion) Overview, By Product Type, 2015-2025 8.1.6 Europe Antidiabetic Drug Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 9 Asia Pacific Antidiabetic Drug Market Analysis 9.1 Asia Pacific Market Snapshot 9.1.1 Asia Pacific Antidiabetic Drug Market Revenue and Growth Rate (%), 2015-2025. 9.1.2 Asia Pacific Antidiabetic Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 9.1.3 Asia Pacific Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 9.1.5 Asia Pacific Antidiabetic Drug Revenue (USD Billion) Overview, By Product Type, 2015-2025 9.1.6 Asia Pacific Antidiabetic Drug Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 10 Latin America Antidiabetic Drug Market Analysis 10.1 Latin America Market Snapshot 10.1.1 Latin America Antidiabetic Drug Market Revenue and Growth Rate (%), 2015-2025. 10.1.2 Latin America Antidiabetic Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 10.1.3 Latin America Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 10.1.5 Latin America Antidiabetic Drug Revenue (USD Billion) Overview, By Product Type, 2015-2025 10.1.6 Latin America Antidiabetic Drug Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 11 Middle East & Africa Antidiabetic Drug Market Analysis 11.1 Middle East & Africa Market Snapshot 11.1.1 Middle East & Africa Antidiabetic Drug Market Revenue and Growth Rate (%), 2015-2025. 11.1.2 Middle East & Africa Antidiabetic Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 11.1.3 Middle East & Africa Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 11.1.5 Middle East & Africa Antidiabetic Drug Revenue (USD Billion) Overview, By Product Type, 2015-2025 11.1.6 Middle East & Africa Antidiabetic Drug Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 12 Competitive Analysis 12.1 Company 1. 12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 12.1.2 Company 1. Total Company Revenue 2015-2018 12.1.3 Company 1. Total Company Revenue, By Segment of Business 2015-2018 12.1.4 Company 1. Total Company Revenue, By Region 2015-2018 12.1.5 Company 1. Global Antidiabetic Drug Product Category and Description 12.1.6 Company 1. Recent Activity 2015-2019 12.1.7 Main Business/Business Overview 12.1.8 Business Strategy 12.1.9 SWOT Analysis 12.2 Company 2. 12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 12.2.2 Company 2. Total Company Revenue 2015-2018 12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018 12.2.4 Company 2. Total Company Revenue, By Region 2015-2018 12.2.5 Company 2. Global Antidiabetic Drug Product Category and Description 12.2.6 Company 2. Recent Activity 2015-2019 12.2.7 Main Business/Business Overview 12.2.8 Business Strategy 12.2.9 SWOT Analysis 12.3 Company 3 12.3.1 Business Overview 12.3.2 Company 3Market Product Category and Description & Specification 12.3.3 Main Business/Business Overview 12.3.4 Business Strategy 12.3.5 SWOT Analysis 12.4 Company 4. 12.4.1 Business Overview 12.4.2 Company 4.Company Total Company Revenue 2015-2018 12.4.3 Company 4.Company Total Company Revenue, By Segment of Business 2015-2018 12.4.4 Company 4.Company Total Company Revenue, By Region of Business 2015-2018 12.4.5 Company 4.Company Product Category, Specification and Description 12.4.6 Company 4.Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019 12.4.7 Company 4.Company Main Business/Business Overview 12.4.8 Business Strategy 12.4.9 SWOT Analysis 12.5 Company 5 12.5.1 Business Overview 12.5.2 Company 5 Company Net Sales 2015-2018 12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018 12.5.4 Company 5 Company Net Sales, By Region 2015-2018 12.5.5 Company 5 Antidiabetic Drug Market Product Category and Specification 12.5.6 Company 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 12.5.7 Company 5 Main Business/Business Overview 12.5.8 Business Strategy 12.5.9 SWOT Analysis 12.6 Company 6 12.6.1 Business Overview 12.6.2 Company 6 Antidiabetic Drug Market Product Category and Specification 12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 12.6.4 Company 6 Main Business/Business Overview 12.6.5 Business Strategy 12.6.6 SWOT Analysis Chapter 13 Market Research Findings & Conclusion Chapter 14 Research Methodology 14.1 Research Process 14.2 Primary Research 14.3 Secondary Research 14.4 Market Size Estimates 14.5 Forecast Model 14.7 Who is This Report For? 14.8 USP’s of Report List of Figures FIG. 1 Global Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025 FIG. 4 Global Antidiabetic Drug Market: Attractiveness Analysis By Product Type FIG. 5 Global Antidiabetic Drug Market: Attractiveness Analysis By Type FIG. 6 Global Antidiabetic Drug Market: Attractiveness Analysis by Regional FIG. 7 Global Antidiabetic Drug Market FIG. 8 Global Antidiabetic Drug Market Share (%), By Product Type, 2018 FIG. 9 Global Antidiabetic Drug Market Revenue (USD Billion), By Application, 2015-2025 FIG. 10 Global Antidiabetic Drug Market Revenue (USD Billion), By End Use , 2015-2025 FIG. 10 Global Antidiabetic Drug Market Revenue (USD Billion), By Type, 2015-2025 FIG. 11 Global Antidiabetic Drug Market Revenue Market Share (%), By Product Type, 2015-2025 FIG. 20 North America Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 21 North America Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 22 Europe Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 23 Europe Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 24 Asia Pacific Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 25 Asia Pacific Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 26 Latin America Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 27 Latin America Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 28 Middle East & Africa Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 29 Middle East & Africa Antidiabetic Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 30 Company 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) FIG. 31 Company 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 32 Company 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million) FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 119 FIG. 36 Company 3 Total Company Revenue 2015-2018 (USD Million) FIG. 37 Company 3 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 38 Company 3 Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %) FIG. 39 Company 4. Company Net Sales 2015-2018 (USD Million, R & D Expenses %) FIG. 40 Company 4. Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 41 Company 4. Company Net Sales, by Region 2015-2018 (USD Million, AGR %) FIG. 42 Company 5 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) FIG. 43 Company 5 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 44 Primary Research FIG. 45 Sources of Secondary Research FIG. 46 Forecast Model List of Tables TABLE 1 Global Antidiabetic Drug Market Overview TABLE 2 Market Driver Impact Analysis TABLE 3 Market Restraints Impact Analysis TABLE 4 Global Antidiabetic Drug market Revenue (USD Billion), By Players2018 TABLE 5 Global Antidiabetic Drug market Revenue Market share (%), By Players- 2018 TABLE 6 Global Antidiabetic Drug Market Revenue (USD Billion), By Product Type, 2015 - 2025 TABLE 7 Global Antidiabetic Drug Market Revenue Share (%), By Product Type, 2015 - 2025 TABLE 8 Global Antidiabetic Drug Market Revenue (USD Billion), By Product Type, 2015 - 2025 TABLE 9 Global Antidiabetic Drug Market Revenue Share (%), By Product Type, 2015 - 2025 TABLE 10 Global Antidiabetic Drug Market Revenue (USD Billion), 2015 - 2025 TABLE 11 Global Antidiabetic Drug Market Revenue Share (%), By , 2015 - 2025 More …………...